What's breaking now, across thousands of outlets.
Cerevance plans to meet with the FDA to “determine next steps” for a new kind of medicine known as solengepras, now that it has Phase 3 data in hand.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
A brain cancer effort more than a decade in the making has culminated in a disappointing study result — but researchers behind it are contending there’s enough of a promising signal to give certain…
Chen Yu's TCGX, a private and public biotech investment firm, is going to invest directly in life sciences companies in China and elsewhere in Asia.
Children living in houses improved through the Healthy Homes Initiative were found to be 30% less likely to be hospitalized in the following five years, according to research led by the University of…
Collaborative surveillance implementation guide orlunwop@who.int Wed, 07/10/2026 - 13:01 At the Seventy-fifth World Health Assembly in May 2022, the WHO Director- General presented a harmonized…
Interior Minister Abdulaziz bin Saud expresses gratitude to the leadership for launching the 2026 national blood donation campaign, highlighting its vital role.
HHOM said it takes fall reports "seriously", and has since followed up with the facility on areas of improvement.
